Day: March 11, 2026

us corporate news

MediciNova, Inc. 2025 Annual Report: Advancing MN-166 and MN-001 Therapies for Neurological and Metabolic Diseases

Minichart

March 11, 2026

Product Development and Commercialization Risks: The company...

Continue Reading 0

us corporate news

Westrock Coffee Company 2025 Annual Report: Key Risks, Business Overview, and Financial Highlights

Minichart

March 11, 2026

Westrock Coffee Company 2025 Annual Report: Key Takeaways fo...

Continue Reading 0

us corporate news

Voyager Technologies, Inc. 2025 Annual Report: Defense, Space Solutions, and Starlab Space Station Business Overview and Risk Factors

Minichart

March 11, 2026

Voyager Technologies 2025 Annual Report: Key Highlights and ...

Continue Reading 0

us corporate news

CoinShares Bitcoin ETF Annual Report 2025: Business Overview, Risk Factors, and Regulatory Insights

Minichart

March 11, 2026

CoinShares Bitcoin ETF (Nasdaq: BRRR) has released its lates...

Continue Reading 0

us corporate news

Willis Lease Finance Corporation 2025 Annual Report – Aircraft Engine Leasing, Spare Parts Sales, Competition, and Risk Management

Minichart

March 11, 2026

Willis Lease Finance Corporation (WLFC) 2025 Annual Report: ...

Continue Reading 0

us corporate news

Global Indemnity Group, LLC 2025 Annual Report | Business Segments, Insurance Products, and Financial Disclosures

Minichart

March 11, 2026

Global Indemnity Group, LLC: 2025 Annual 10-K Filing – Key I...

Continue Reading 0

us corporate news

LaFayette Acquisition Corp. 2025 Annual Report: Business Strategy, Risk Factors, and SPAC Acquisition Criteria

Minichart

March 11, 2026

LaFayette Acquisition Corp. 2025 Annual Report: In-Depth Ana...

Continue Reading 0

us corporate news

Athena Technology Acquisition Corp. II 2025 Annual Report: Business Overview, Risks, and Ace Green Recycling Merger Plans

Minichart

March 11, 2026

Athena Technology Acquisition Corp. II Files 2025 Annual Rep...

Continue Reading 0

us corporate news

Sagimet Biosciences Advances FASN Inhibitor Pipeline with Positive Phase 3 Results for Denifanstat in Acne and MASH Clinical Trials

Minichart

March 11, 2026

Sagimet Biosciences Inc. Issues Annual Report for Fiscal Yea...

Continue Reading 0

us corporate news

Katapult 2025 Annual Report: Innovative Lease-to-Own Solutions, Technology, and Key Business Risks

Minichart

March 11, 2026

Katapult Holdings, Inc. 2025 Annual Report: Key Highlights a...

Continue Reading 0